SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

Encouraging early zugo-cel data in autoimmune diseases is drawing attention: traders highlight responses in systemic sclerosis and inflammatory myopathy, alongside a favorable initial safety read across 21 patients. Bulls see promise in the off-the-shelf CD19 CAR-T approach, while others stress that the small cohorts and early follow-up leave efficacy and safety to be confirmed.

iShares Inc. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

EWY is rebounding with South Korean equities and memory-chip stocks after a sharp AI-related selloff and forced deleveraging. Traders are debating whether the bounce signals stabilization or is temporary, with KOSPI volatility keeping sentiment cautious.

Nasdaq, Inc. is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information, and public and private company services. It operates through the following segments: Capital Access Platforms, Financial Technology, and Market Services. The Capital Access Platforms segment delivers liquidity, transparency, and integrity to the corporate issuer and investment community by empowering clients to effectively navigate the capital markets, achieve their sustainability goals, and drive governance excellence. The Financial Technology segment offers platforms that improve the liquidity, transparency, and integrity of the global economy by architecting and operating the markets. The Market Services segment includes equity derivative trading and clearing, cash equity trading, fixed income, currency, and commodities trading. The company was founded by Gordon S. Macklin in 1971 and is headquartered in New York, NY.

Nasdaq Inc

Discussion is fragmented, with the most common theme being swings in the broader Nasdaq and tech market: traders debate whether selloffs will deepen or give way to a rebound. Company-specific posts also point to recent quarterly results and Nasdaqs planned extended-hours trading, but neither clearly dominates the conversation.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Attention centers on Alpha Taus clinical pipeline: traders are watching for further REGAIN glioblastoma data, updates from the completed-enrollment IMPACT pancreatic trial, ReSTART results, and a possible FDA IDE for the Keytruda combination. The community is broadly bullish on the upcoming milestones and recent share-price strength, though some are waiting for confirmed updates rather than speculating about the next announcement.

Litecoin (LTC) is a cryptocurrency . Users are able to generate LTC through the process of mining. Litecoin has a current supply of 84,000,000 with 77,805,873.7130931 in circulation. The last known price of Litecoin is 52.00804602 USD and is down -0.75 over the last 24 hours. It is currently trading on 1567 active market(s) with $117,565,973.29 traded over the last 24 hours. More information can be found at https://litecoin.org/.

Litecoin

Litecoins pullback and weak performance after earlier rallies are driving discussion, with traders parsing technical support and some treating the decline as an accumulation opportunity. Others argue LTC repeatedly gives back gains and may remain under pressure, while bullish breakout and squeeze calls remain speculative.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTechs quarterly results and raised full-year revenue guidance are drawing attention, alongside progress in its cancer pipeline as COVID-related revenue wanes. Traders see the update as support for its oncology transition, while others remain cautious about clinical execution and compare its performance unfavorably with Moderna.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AIs quarterly results beat expectations and the company raised its full-year revenue outlook, prompting a bullish reaction and heavy focus on call-option activity. Traders are debating whether momentum will continue or fade, while some remain cautious about volatility, valuation, and how quickly hospitals will adopt its AI products.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zoom is drawing attention ahead of earnings, with traders debating whether its AI products can drive new growth as rivals bundle similar meeting tools and companies trim paid seats. Skeptics see a mature, low-growth business with limited upsell potential, while others are watching the $90 level for a technical rebound.

Dow, Inc. is a holding company, which engages in the development of innovative solutions. It operates through the following segments: Packaging and Specialty Plastics, Industrial Intermediates and Infrastructure, and Performance Materials and Coatings. The Packaging and Specialty Plastics segment consists of hydrocarbons and energy and packaging and specialty plastics. The Industrial Intermediates and Infrastructure segment covers the industrial solutions and polyurethanes, and construction of chemicals. The Performance Materials and Coatings segment includes coatings and performance monomers, and consumer solutions. The company was founded in 1897 and is headquartered in Midland, MI.

Dow Inc

Unusual options and elevated dark-pool activity are drawing attention, with traders noting fresh positioning on both calls and puts and debating whether the put flow reflects hedging or a bearish view. The broader discussion is directionally mixed, with some traders expecting further weakness and others watching for a rebound.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Attention centers on povetacicepts upcoming FDA decision for IgA nephropathy, following positive Phase 3 RAINIER results; traders are bullish on its potential as a new growth pillar, though approval and commercial upside remain uncertain. Q3 results also drew mixed reactions, with revenue growth and raised guidance weighed against an adjusted EPS miss and concerns about valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why GoDaddy (GDDY) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

GoDaddy: 3 Key Takeaways for Long-Term Investors

Key PointsAiro annualized bookings run rate doubled to over $100 million...

GDDY Q3 Earnings Beat Estimates on Revenue Growth and Airo Gains

GoDaddy's Q3 2026 earnings beat estimates as revenues increased 6%, fueled by accelerating Airo adoption, stronger customer monetization, and broad segment growth.


GoDaddy Q3 2026 Earnings Call Transcript

GoDaddy (NYSE:GDDY) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...

Compared to Estimates, GoDaddy (GDDY) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for GoDaddy (GDDY) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

GoDaddy (GDDY) Beats Q3 Earnings and Revenue Estimates

GoDaddy (GDDY) delivered earnings and revenue surprises of +14.29% and +1.10%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

GoDaddy Inc. Reports Third Quarter 2026 Financial Results

GoDaddy Inc. Reports Third Quarter 2026 Financial Results GoDaddy Inc. Reports Third Quarter 2026 Financial ResultsPR NewswireTEMPE, Ariz., Oct. 29, 2026 TEMPE, Ariz., Oct. 29, 2026 /PRNewswire/ -- GoDaddy Inc. (NYSE: GDDY) today reported third quarter 2026 financial results. To view the earnings...

LAWSUIT ALERT: GoDaddy Inc. (NYSE: GDDY) Investors Should Contact the Shareholders Foundation

LAWSUIT ALERT: GoDaddy Inc. (NYSE: GDDY) Investors Should Contact the Shareholders Foundation LAWSUIT ALERT: GoDaddy Inc. (NYSE: GDDY) Investors Should Contact the Shareholders FoundationPR NewswireSAN DIEGO, October 29, 2026 SAN DIEGO, October 29, 2026 /PRNewswire/ -- The Shareholders Foundation...

GoDaddy to Report Q3 Earnings: What's in Store for the Stock?

GDDY Q3 results are likely to benefit from AI-powered Airo adoption, Applications & Commerce growth, and resilient domain demand.


Here's Why GoDaddy (GDDY) is a Strong Growth Stock

• Reported GAAP EPS of $2.08 up 37.75% YoY
• Reported revenue of $1.34B up 6.05% YoY
• For the full year ending December 31, 2026, GoDaddy expects revenue toward the higher end of $5.22B to $5.26B, NEBITDA margin over 33%, and free cash flow approximately $1.8B.

GoDaddy's Core segment EBITDA margin was 32.9% versus 33.0% a year earlier; net debt was $2.7B; disclosed risks include the unpredictable nature of a rapidly evolving market, competition, cyberattacks, and service interruptions.

GoDaddy's Airo exceeded a $100M annualized bookings run rate and began contributing to bookings growth; its Developer Platform added agent-friendly APIs, while operating income and free cash flow increased year over year.

GoDaddy, Inc. engages in the provision of simple and easy-to-use products on a single technology platform, complemented by personalized guidance. It operates through the following segments: Applications and Commerce (A&C) and Core Platform (Core). The Applications and Commerce (A&C) segment sells products containing proprietary software, commerce solutions, third-party email services, productivity tools, and certain products bundled with proprietary software offerings. The Core Platform (Core) segment provides domain registrations and renewals, aftermarket domain sales, website hosting services, website security products that are not included in bundled proprietary software offerings, and other products that do not contain a software component. The company was founded by Robert R. Parsons in 1997 and is headquartered in Tempe, AZ.

Godaddy Inc - Ordinary Shares - Class A

GoDaddy Shares Surge On Gen Digital's Reported Takeover Bid — GEN Stock Falls As Talks in Early Stages

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>The FT report did not disclose financial terms of the potential transaction.</li><li>The initial approach was reportedly made in recent weeks and discussions remain at an early stage.</li><li>A combination would bring together GoDaddy’s domains, hosting and payments business with Gen Digital’s Norton, Avast and LifeLock cybersecurity portfolio.</li></ul>GoDaddy Inc. (GDDY) shares spiked as much as 11% Thursday after it was reported that Gen Digital Inc. (GEN), the company behind Norton and Avast, had made a takeover approach for the web-services company.Gen Digital made its first approach to GoDaddy in recent weeks. Discussions between the companies are still at an early stage and there is no guarantee the approach will ultimately lead to a transaction, the Financial Times&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.ft.com/content/6cc7149f-a9f1-47f6-9faf-b98a28f9aedc?syn-25a6b1a6=1">reported</a>, citing people familiar with the matter.The report did not disclose the financial terms of Gen Digital’s approach. A potential transaction would bring together businesses operating in different areas of the consumer internet market. GEN stock was down nearly 8% at the time of this writing. GoDaddy provides domain registration, website hosting, website-building tools and payments services, primarily for small businesses and individual customers. Gen Digital owns consumer cybersecurity and identity-protection brands including Norton, Avast and LifeLock.&nbsp;<h2 class="st-heading-2">Stocks Have Been Under Pressure</h2>Both companies entered Thursday after sharp losses earlier in the week.&nbsp;<a href="https://stocktwits.com/symbol/GDDY">GDDY</a> fell more than 7% in the last two sessions, while&nbsp;<a href="https://stocktwits.com/symbol/GEN">GEN</a> stock tanked as much as 10% over this period.Divergent moves between takeover targets and prospective buyers are common around acquisition announcements. Targets often gain on the takeover premium, while buyers can lag as investors weigh deal economics. That may not explain this move, though, since the FT report did not disclose terms or financing.<h2 class="st-heading-2">Retail Sentiment Around GDDY and GEN</h2>At the time of this writing, retail investor sentiment around GDDY stock on Stocktwits was ‘neutral’, while sentiment around GEN stock remained ‘bearish’So far this year, GDDY stock has fallen more than 15%. In comparison, the Invesco S&amp;P 500 Equal Weight Technology ETF (<a href="https://stocktwits.com/symbol/RSPT">RSPT</a>), which holds the stock, has risen over 43% during this period.Meanwhile, GEN stock has fallen more than 5% year-to-date. In comparison, the Global X Cybersecurity ETF (<a href="https://stocktwits.com/symbol/BUG">BUG</a>), which holds GEN shares, has soared more than 57% over the same period.See Also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/everpure-stock-soars-to-record-high-top-street-target-sees-64-upside-on-stronger-growth-outlook/cZMJdzmRB9S">Everpure Stock Soars To Record High — Top Street Target Sees 64% Upside On Stronger Growth Outlook</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

SAN ANSELMO, CALIFORNIA - APRIL 04: In this photo illustration, the GoDaddy app is displayed on an iPhone screen on April 04, 2024 in San Anselmo, California. (Photo Illustration by Justin Sullivan/Getty Images)

GoDaddy Inc. (GDDY) shares spiked as much as 11% Thursday after it was reported that Gen Digital Inc. (GEN), the company behind Norton and Avast, had made a takeover approach for the web-services company.

According to the Financial Times, Gen Digital has approached GoDaddy about a takeover, but discussions remain at an early stage and there is no certainty they will result in a deal.

Global X Funds - Global X Cybersecurity ETF

Gen Digital Inc

Invesco S&P 500 Equal Weight Technology ETF

$RDDT

$RBLX

$COIN

$GDDY

Reddit, Roblox, Coinbase, and GoDaddy stocks are moving lower following their respective earnings releases. Which are you thinking about buying? Explain your reasoning in the comments.

Reddit ($RDDT), Roblox ($RBLX), Coinbase ($COIN), and GoDaddy ($GDDY) are down following earnings results - which are you most interested in buying on the dip?

Stocktwits

Reddit Inc

Roblox Corp.

Coinbase Global Inc

) are down following earnings results - which are you most interested in buying on the dip?

Feed

News

Sentiment

Earnings

Fundamentals

Info

GDDY News